Description
Adamax is a semisynthetic neuropeptide derivative of Semax, characterized by the addition of an N-terminal acetyl group and a C-terminal adamantane moiety. These structural modifications are designed to significantly enhance lipophilicity, improve resistance to enzymatic degradation, and facilitate greater stability compared to the parent peptide. Derived from the P21 peptide framework, Adamax is utilized in research to investigate potential neurogenic and cognitive-modulating mechanisms.










Reviews
There are no reviews yet.